5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.35▲ | 2.35▲ | 2.36▼ | 2.38▼ | 2.58▼ |
MA10 | 2.35▲ | 2.37▼ | 2.38▼ | 2.40▼ | 2.62▼ |
MA20 | 2.35▼ | 2.38▼ | 2.39▼ | 2.60▼ | 2.56▼ |
MA50 | 2.37▼ | 2.39▼ | 2.38▼ | 2.63▼ | 2.75▼ |
MA100 | 2.39▼ | 2.39▼ | 2.47▼ | 2.56▼ | 4.09▼ |
MA200 | 2.40▼ | 2.49▼ | 2.65▼ | 2.63▼ | 6.90▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | -0.006▼ | -0.007▼ | -0.025▼ | 0.003▲ |
RSI | 40.777▼ | 38.740▼ | 39.836▼ | 38.334▼ | 43.840▼ |
STOCH | 36.111 | 6.027▼ | 18.519▼ | 19.339▼ | 41.707 |
WILL %R | -75.000▼ | -94.444▼ | -94.444▼ | -93.617▼ | -84.848▼ |
CCI | 7.778 | -86.420 | -129.190▼ | -64.451 | -88.065 |
Wednesday, October 15, 2025 12:02 PM
It hits us in the gut when we see fellow investors suffer a loss. Anyone who held Eventbrite, Inc. (NYSE:EB) for five years would be nursing their metaphorical wounds since the share price dropped 74% ...
|
Wednesday, October 15, 2025 05:47 AM
Enveric Biosciences (NASDAQ: ENVB) has hired prominent intellectual property law firm Fish and Richardson P.C. to contest a Post-Grant Review (PGR) petition filed by Gilgamesh Pharmaceuticals, which ...
|
Wednesday, October 15, 2025 05:32 AM
Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/10/25 | 2.42 | 2.4419 | 2.34 | 2.36 | 482,604 |
14/10/25 | 2.37 | 2.425 | 2.37 | 2.39 | 265,757 |
13/10/25 | 2.35 | 2.42 | 2.35 | 2.42 | 462,041 |
10/10/25 | 2.38 | 2.41 | 2.33 | 2.33 | 577,335 |
09/10/25 | 2.38 | 2.40 | 2.3544 | 2.39 | 435,568 |
08/10/25 | 2.35 | 2.425 | 2.33 | 2.40 | 673,205 |
07/10/25 | 2.44 | 2.49 | 2.33 | 2.35 | 496,506 |
06/10/25 | 2.50 | 2.5399 | 2.41 | 2.45 | 627,713 |
03/10/25 | 2.45 | 2.53 | 2.44 | 2.50 | 456,733 |
02/10/25 | 2.45 | 2.46 | 2.395 | 2.43 | 591,664 |
|
|
||||
|
|
||||
|
|